Duopharma Biotech Bhd is expected to stay resilient amid geopolitical uncertainties, supported by limited exposure to Middle East markets and stronger ASEAN export prospects. | Collector
The Star
Duopharma Biotech Bhd is expected to stay resilient amid geopolitical uncertainties, supported by limited exposure to Middle East markets and stronger ASEAN export prospects.
Duopharma Biotech Bhd is expected to stay resilient amid geopolitical uncertainties, supported by limited exposure to Middle East markets and stronger ASEAN export prospects.
The Star